FLGT (Fulgent Genetics) Intangible Assets: $203.1 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FLGT Fulgent Genetics Inc FLGT
65 GF Score
Price $19.81
GF Value $24.20
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Fulgent Genetics Intangible Assets?

Fulgent Genetics FLGT -0.58% 65 Intangible Assets is $203.1 Mil as of Jun. 2026. GuruFocus rates FLGT with a GF Score™ of 65/100 and a GF Value™ of $24.20 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Fulgent Genetics's intangible assets for the quarter that ended in Jun. 2026 was $203.1 Mil.


Fulgent Genetics  (NAS:FLGT) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Fulgent Genetics Intangible Assets Related Terms


Fulgent Genetics Intangible Assets Historical Data

* Premium members only.

The historical data trend for Fulgent Genetics's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fulgent Genetics Intangible Assets Chart

Fulgent Genetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Intangible Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.81 293.67 165.11 157.03 158.36

Fulgent Genetics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 153.12 160.34 158.36 207.72 203.12
FLGT
65GF Score
Fulgent Genetics Inc FLGT
Intangible Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fulgent Genetics Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.

Frequently Asked Questions Learn more about Intangible Assets →
What does a Intangible Assets of $203.1 Mil mean?
Fulgent Genetics (FLGT) has a Intangible Assets of $203.1 Mil as of Jun. 2026. Intangible assets include patents, goodwill and trade secrets. View historical data on Fulgent Genetics and its competitors.
Is Fulgent Genetics' Intangible Assets too high?
Fulgent Genetics' current Intangible Assets is $203.1 Mil. Overall, Fulgent Genetics has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' Intangible Assets compare to MYGN and CSTL?
Fulgent Genetics' Intangible Assets of $203.1 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intangible Assets for a Medical Diagnostics & Research company?
A good Intangible Assets depends on the Medical Diagnostics & Research industry context. However, Intangible Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intangible Assets mean?
A high Intangible Assets can signal that a stock is expensive relative to its fundamentals. Intangible assets include patents, goodwill and trade secrets. View historical data on Fulgent Genetics and its competitors. Fulgent Genetics's current Intangible Assets is $203.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Based on GuruFocus' analysis, Fulgent Genetics (FLGT) is currently considered Modestly Undervalued. The stock's GF Value™ is $24.20, compared to a current price of $19.81 — trading 18.1% below its estimated fair value. The current Intangible Assets is $203.1 Mil. Fulgent Genetics' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intangible Assets calculated?
Intangible Assets is calculated from a company's financial statements. For Fulgent Genetics (FLGT), the current Intangible Assets is $203.1 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (FLGT) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of $19.81 is trading 18.1% below its estimated GF Value™ of $24.20. GuruFocus considers Fulgent Genetics to be Modestly Undervalued.

Key valuation signals for FLGT:

  • Intangible Assets: $203.1 Mil
  • GF Value™: $24.20 vs. price of $19.81 (18.1% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fulgent Genetics Business Description

Other Exchanges FLGT:Mexico
Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
65GF Score

Get the complete analysis for FLGT

Intangible Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.81
Price
$24.20
GF Value